Simple blood test could revolutionize cancer monitoring

NCT ID NCT04530890

Summary

This study aims to see if tracking tiny pieces of tumor DNA and other markers in the blood can help doctors better understand and monitor breast, digestive, and gynecologic cancers. Researchers will follow 1,000 patients to see if these blood tests can predict how well treatments are working, when cancer might return, and overall patient survival. The goal is to gather evidence to improve how cancer is managed using less invasive methods than traditional biopsies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU POitiers

    RECRUITING

    Poitiers, France

    Contact

Conditions

Explore the condition pages connected to this study.